Doctor profile · Federal record
Dr. TAYLOR TENNILL, MD
Dermatology Physician (CMS: DERMATOLOGY) · SPRINGFIELD, IL
- NPI 1801202833
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 11 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1025 S 6TH ST
SPRINGFIELD, IL 62703
(217) 528-7541
Credentials & registration
- NPI registered
- July 2014 — 12 yrs on file
- Profile last updated
- May 19, 2020
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Illinois #036145217
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1801202833. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,228
Distinct HCPCS
10
Medicare allowed
$216,072
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 997 | 214 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 597 | 497 | $88 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 393 | 302 | $124 | |
17000 |
Destruction of precancer skin growth, 1 growth | 377 | 314 | $52 | |
11102 |
Biopsy of related skin growth, first growth | 177 | 158 | $87 | |
17110 |
Destruction of skin growth, 1-14 growths | 150 | 140 | $102 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 110 | 110 | $108 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 82 | 82 | $161 | |
11103 |
Biopsy of related skin growth, each additional growth | 60 | 43 | $47 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 59 | 15 | $1 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 240. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$294
Transactions
9
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 2 | $147.38 | |
| ABBVIE INC. | 3 | $76.94 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $30.54 | |
| GENZYME CORPORATION | 1 | $24.11 | |
| PFIZER INC. | 1 | $15.27 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
937
Patients
474
Total drug cost
$368,183
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 217 | 132 | $11,940 |
| Doxycycline Hyclate | Generic | 128 | 53 | $4,529 |
| Spironolactone | Generic | 84 | 18 | $1,760 |
| Triamcinolone Acetonide | Generic | 74 | 58 | $824 |
| Ketoconazole | Generic | 73 | 49 | $1,193 |
| Otezla (Apremilast) | Brand | 69 | 11 | $339,578 |
| Mupirocin | Generic | 50 | 24 | $388 |
| Clindamycin Phosphate | Generic | 48 | 20 | $1,091 |
| Fluorouracil | Generic | 36 | 34 | $4,021 |
| Imiquimod | Generic | 32 | 21 | $1,319 |